Photo from wikipedia
Available evidence demonstrates a crosstalk between the renin–angiotensin and the parathyroid hormone–vitamin D systems. A new study suggests that vitamin D supplementation can lower systolic blood pressure and plasma aldosterone… Click to show full abstract
Available evidence demonstrates a crosstalk between the renin–angiotensin and the parathyroid hormone–vitamin D systems. A new study suggests that vitamin D supplementation can lower systolic blood pressure and plasma aldosterone levels in patients with primary aldosteronism.
Keywords:
supplementation;
therapy aldosteronism;
supplementation novel;
vitamin supplementation;
novel therapy
Journal Title: Nature Reviews Endocrinology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Reviews Endocrinology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!